Le Lézard
Classified in: Health
Subject: MAT

Ideal Implant Announces FDA Approval to Manufacture with Vesta


DALLAS, April 26, 2018 /PRNewswire-PRWeb/ -- Ideal Implant Incorporated announced today that they received FDA approval to manufacture their Structured Breast Implant at Vesta, a Lubrizol LifeSciences company and a leading medical device contract manufacturer of silicone products and other medical devices, as of March 13, 2018.

Robert S. Hamas, MD ?Chief Executive Officer of Ideal Implant Incorporated, stated, "This new partnership with Vesta, significantly increases IDEAL IMPLANT® production volume, while also allowing for refinements to the manufacturing process. We now have the manufacturing capacity to grow our share of the U.S. and Canadian breast implant markets and expand into international markets."

Dr. Hamas continued, "Vesta will be a great asset to the growth of Ideal Implant and we look forward to providing board certified plastic surgeons our implants from this high-quality US manufacturer. "

Ideal Implant will be a participant in the upcoming American Society of Aesthetic Plastic Surgery (ASAPS) meeting at the Jacob Javits Center in New York City on April 28-30, 2018. Samples of the new product will be on display in the company's booth #163.

About Ideal Implant Incorporated

Headquartered in Dallas, Texas, Ideal Implant Incorporated is a breast implant company founded by Robert S. Hamas, MD who also invented the IDEAL IMPLANT after years of dealing with ruptured silicone gel implants and listening to patients concerns. Dr. Hamas realized that women wanted a new type of breast implant ? one that would combine the natural feel of a silicone gel implant with only saline inside for safety and peace of mind.

Today, Ideal Implant Incorporated is majority owned by plastic surgeons, making it the "Plastic Surgeons' Breast Implant Company." Because of this, the company has a strong focus on patient care and safety, with particular emphasis on attention to detail and quality control in manufacturing of the IDEAL IMPLANT. For more information, please visit the company's website at idealimplant.com

About Vesta

Headquartered in Franklin, Wisconsin, Vest Intermediate Funding, Inc. ("Vesta") is a Lubrizol LifeSciences company. Vesta has more than 40 years of experience serving the medical device industry. Vesta's quality competency and reliability have earned the company business relationships with hundreds of OEMs worldwide. For more information, please visit the company's website at http://www.vestainc.com or contact Vesta at info(at)vestainc(dot)com.

 

SOURCE Ideal Implant Incorporated


These press releases may also interest you

at 14:24
Evermore Cannabis Company, a leader in innovative cannabis cultivation and product development, is thrilled to announce its remarkable success at the first-ever Maryland Leaf Bowl, held on April 13th. Demonstrating excellence across multiple...

at 14:23
Autolomous, the market-leading developer of critical manufacturing management systems for cell and gene therapies, and BioCentriq, industry-leading clinical-phase Cell Therapy CDMO (contract development and manufacturing organization), announce a...

at 14:15
As patients with congenital heart diseases live longer, researchers are attempting to understand some of the other complications they may face as they age. In a new study, a team from Children's Hospital of Philadelphia (CHOP) used state-of-the-art...

at 14:08
Seacoast Laboratory Data Systems, a nationwide leader in providing customizable LIS and AR software solutions for commercial and...

at 14:05
The Atrium at Cardinal Drive, a Benchmark Mind & Memory Care community, has ranked among the best assisted living with memory care communities in Massachusetts and the entire U.S. for the second straight year. In U.S. News & World Report's third...

at 14:04
The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) is proud to announce the recipients of the 2024 ADLM and Academy of Diagnostics & Laboratory Medicine Awards. Through this annual awards program, ADLM and its Academy...



News published on and distributed by: